Document is current
Any future updates will be listed below
-
Authors
Kirkland, Anna E. https://orcid.org/0000-0001-5308-2423
Browning, Brittney D.
Green, ReJoyce
Liu, Helen
Maralit, Anna M.
Ferguson, Pamela L. https://orcid.org/0000-0002-4210-2625
Meyerhoff, Dieter J. https://orcid.org/0000-0002-2433-7826
Prisciandaro, James J.
Miranda, Robert Jr.
Brady, Kathleen T.
Tomko, Rachel L.
Gray, Kevin M.
Squeglia, Lindsay M. https://orcid.org/0000-0001-5994-6894
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (F32-AA029930-01A1, T32AA007474-35, T32AA007474-35, K23-AA025399)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (T32DA007288-31)
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism
- License Information
-
More Information
Article History
Received: 26 October 2022
Revised: 26 January 2023
Accepted: 13 February 2023
First Online: 6 March 2023
Competing interests
: KMG has provided consultation to Jazz Pharmaceuticals and has received research funding from Aelis Farma. RLT has received funding from the American Society of Addiction Medicine. The authors declare no other competing interests.
